PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity - Moraes Ribeiro, Emmanuelle; Secker, Kathy-Ann; Nitulescu, Ana-Maria; Schairer, Rebekka; Keppeler, Hildegard; Wesle, Anton; Schmid, Hannes; Schmitt, Anita; Neuber, Brigitte; Chmiest, Daniela; Podavini, Silvia; Märklin, Melanie; et al. (Journal for ImmunoTherapy of Cancer, 2024)
Zuerst veröffentlicht: 31. Januar 2024